Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Peptan Hydrolyzed Collagen May Prevent Bone Loss - Nutraceuticals World

What are you searching for?

Sign in
Research

Peptan Hydrolyzed Collagen May Prevent Bone Loss

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

A new study from Rousselot and published in Osteoporosis International in September confirms the benefits of Peptan hydrolyzed collagen on bone health. Research was conducted at AgroParisTech, Nutrition Physiology and Ingestive Behavior laboratory.

The aim of this study was to evaluate the effect of Peptan on the bone health of ovariectomized mice (OVX) of different ages. Animals were divided into different groups: some groups of mice ingested Peptan after OVX; another group of mice ingested Peptan several weeks before OVX and continued over additional weeks; another ingested Raloxifene—a drug commonly indicated for osteoporosis—instead of hydrolyzed collagen.

Twenty-six weeks after the OVX procedure, Peptan hydrolyzed collagen ingestion improved Bone Mineral Density (BMD) and some femur biomechanical parameters. Moreover, hydrolyzed collagen ingestion for one month before surgery prevented a BMD decrease. The third major finding was that Peptan prevented a decrease in BMD as efficiently as Raloxifene. For further information: www.rousselot.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters